{"id":"W2099555993","doi":"10.3899/jrheum.090307","title":"Sarcoidosis During Anti-Tumor Necrosis Factor-α Therapy: No Relapse After Rechallenge","year":2009,"lang":"en","type":"letter","venue":"The Journal of Rheumatology","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adalimumab; Infliximab; Etanercept; Sarcoidosis; Rheumatoid arthritis; Adverse effect; Neurosarcoidosis; Tumor necrosis factor alpha; Dermatology; Erythema nodosum; Arthritis; Internal medicine; Immunology; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001250124,0.001032776,0.001852889,0.001140391,0.001215123,0.001335864,0.002227777,0.007360301,0.002286688],"category_scores_gemma":[0.007868829,0.0005643761,0.001093199,0.0006562609,0.001256751,0.001841682,0.0004929315,0.004724663,0.001477852],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00116787,"about_ca_system_score_gemma":0.0004389221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008106414,"about_ca_topic_score_gemma":0.001089599,"domain_scores_codex":[0.9988053,0.0002533189,0.0002106789,0.0002670228,0.0001725195,0.0002911967],"domain_scores_gemma":[0.9945763,0.002596413,0.0008494924,0.0003586961,0.0006023318,0.001016699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.0005406348,0.0001936217,0.01062761,0.0002556304,0.00008454148,0.9608701,0.0002811878,0.0001161848,0.0009942846,0.000369523,0.01502483,0.01064181],"study_design_scores_gemma":[0.0001802498,0.0004005174,0.01019288,0.0001624615,0.000106911,0.971641,0.000177745,0.0008114005,0.0009049686,0.0004530053,0.01492025,0.00004860398],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5980676,0.07461015,0.006483043,0.2245807,0.06837502,0.0003369879,0.0006750948,0.0007985507,0.02607292],"genre_scores_gemma":[0.886776,0.01030705,0.001249961,0.03665219,0.05646337,0.00005931316,0.0002960238,0.000124866,0.008071099],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007360301,"threshold_uncertainty_score":0.008473456,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03369657219011801,"score_gpt":0.2902590389633183,"score_spread":0.2565624667732003,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}